Search Results - "Fortmann, Seth"

Refine Results
  1. 1

    AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration by Liu, Yuanyuan, Fortmann, Seth D., Shen, Jikui, Wielechowski, Erik, Tretiakova, Anna, Yoo, Stephen, Kozarsky, Karen, Wang, Jiangxia, Wilson, James M., Campochiaro, Peter A.

    Published in Molecular therapy (07-02-2018)
    “…Sustained suppression of VEGF is needed in many patients with neovascular age-related macular degeneration (NVAMD), and gene transfer of a VEGF-neutralizing…”
    Get full text
    Journal Article
  2. 2

    Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis by Prasad, Ram, Patton, Michael John, Floyd, Jason Levi, Fortmann, Seth, DuPont, Mariana, Harbour, Angela, Wright, Justin, Lamendella, Regina, Stevens, Bruce R, Oudit, Gavin Y, Grant, Maria B

    “…The gut is a well-established route of infection and target for viral damage by SARS-CoV-2. This is supported by the clinical observation that about half of…”
    Get full text
    Journal Article
  3. 3

    Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy by Hammer, Sandra S., Dorweiler, Tim F., McFarland, Delaney, Adu-Agyeiwaah, Yvonne, Mast, Natalia, El-Darzi, Nicole, Fortmann, Seth D., Nooti, Sunil, Agrawal, Devendra K., Pikuleva, Irina A., Abela, George S., Grant, Maria B., Busik, Julia V.

    Published in Diabetologia (01-09-2023)
    “…Aims/hypothesis Hyper-reflective crystalline deposits found in retinal lesions have been suggested to predict the progression of diabetic retinopathy, but the…”
    Get full text
    Journal Article
  4. 4

    Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells by Qiu, Shaowei, Sheth, Vipul, Yan, Chengcheng, Liu, Juan, Chacko, Balu K, Li, Hui, Crossman, David K, Fortmann, Seth D, Aryal, Sajesan, Rennhack, Ashley, Grant, Maria B, Welner, Robert S, Paterson, Andrew J, Wende, Adam R, Darley-Usmar, Victor M, Lu, Rui, Locasale, Jason W, Bhatia, Ravi

    Published in Blood (10-08-2023)
    “…Tyrosine kinase inhibitors (TKIs) are very effective in treating chronic myelogenous leukemia (CML), but primitive, quiescent leukemia stem cells persist as a…”
    Get full text
    Journal Article
  5. 5

    The HIF-1 antagonist acriflavine: visualization in retina and suppression of ocular neovascularization by Zeng, Mingbing, Shen, Jikui, Liu, Yuanyuan, Lu, Lucy Yang, Ding, Kun, Fortmann, Seth D., Khan, Mahmood, Wang, Jiangxia, Hackett, Sean F., Semenza, Gregg L., Campochiaro, Peter A.

    “…Acriflavine, a fluorescent drug previously used for bacterial and trypanosomal infections, reduces hypoxia-inducible factor-1 (HIF-1) and HIF-2 transcriptional…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Reversible retinal vessel closure from VEGF-induced leukocyte plugging by Liu, Yuanyuan, Shen, Jikui, Fortmann, Seth D, Wang, Jiangxia, Vestweber, Dietmar, Campochiaro, Peter A

    Published in JCI insight (21-09-2017)
    “…Clinical trials in patients with macular edema due to diabetic retinopathy or retinal vein occlusion (RVO) have shown that suppression of VEGF not only…”
    Get full text
    Journal Article
  9. 9

    Mousetap, a Novel Technique to Collect Uncontaminated Vitreous or Aqueous and Expand Usefulness of Mouse Models by Fortmann, Seth D., Lorenc, Valeria E., Shen, Jikui, Hackett, Sean F., Campochiaro, Peter A.

    Published in Scientific reports (23-04-2018)
    “…Vitreous or aqueous humour taps are widely used in patients or large animals with retinal diseases to monitor disease biomarkers, search for novel biomarkers,…”
    Get full text
    Journal Article
  10. 10

    Molecular mechanisms of retinal ischemia by Fortmann, Seth D, Grant, Maria B

    Published in Current opinion in physiology (01-02-2019)
    “…•In addition to oxygen deprivation, HIF-1α stabilization is also highly dependent upon the metabolic status of the cell.•β-oxidation is a prominent feature of…”
    Get full text
    Journal Article
  11. 11

    The FDA report on vorapaxar in the elderly: A convoluted dilemma by Serebruany, Victor L, Fortmann, Seth D

    Published in International journal of cardiology (15-12-2015)
    “…Abstract There are consistent data suggesting that elderly patients benefit from less aggressive antiplatelet strategies following acute coronary syndromes…”
    Get full text
    Journal Article
  12. 12

    The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity by Hackett, Sean F, Seidel, Christopher, Abraham, Sheena, Chadha, Rishi, Fortmann, Seth D, Campochiaro, Peter A, Cooke, John P

    “…To investigate the role of nicotinic acetylcholine receptors (nAChRs) in retinal vascular development and ischemia-induced retinal neovascularization (NV). The…”
    Get full text
    Journal Article
  13. 13

    Vorapaxar and optimal aspirin dose: The FDA outlook by Serebruany, Victor L, Fortmann, Seth D, Kim, Moo Hyun

    Published in International journal of cardiology (15-01-2016)
    “…Abstract Vorapaxar, a novel thrombin PAR-1 inhibitor, approved for post-myocardial infarction, and peripheral artery disease indications has been tested in 2…”
    Get full text
    Journal Article
  14. 14

    Disbalance between mortality and non-fatal vascular events in the CHAMPION-PHOENIX trial: the cangrelor efficacy challenge by Serebruany, Victor L, Pokov, Alex N, Fortmann, Seth D, DiNicolantonio, James J

    Published in Thrombosis and haemostasis (01-01-2014)
    “…The recently published, largest trial with cangrelor, the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    Hepatocyte growth factor is upregulated in ischemic retina and contributes to retinal vascular leakage and neovascularization by Lorenc, Valeria E., Lima e Silva, Raquel, Hackett, Sean F., Fortmann, Seth D., Liu, Yuanyuan, Campochiaro, Peter A.

    Published in FASEB bioAdvances (01-04-2020)
    “…In patients with macular edema due to ischemic retinopathy, aqueous levels of hepatocyte growth factor (HGF) correlate with edema severity. We tested whether…”
    Get full text
    Journal Article
  18. 18

    Progenitor cell combination normalizes retinal vascular development in the oxygen-induced retinopathy (OIR) model by Li Calzi, Sergio, Shaw, Lynn C, Moldovan, Leni, Shelley, William C, Qi, Xiaoping, Racette, Lyne, Quigley, Judith L, Fortmann, Seth D, Boulton, Michael E, Yoder, Mervin C, Grant, Maria B

    Published in JCI insight (01-11-2019)
    “…Retinopathy of prematurity (ROP) is a disorder of the developing retina of preterm infants. ROP can lead to blindness because of abnormal angiogenesis that is…”
    Get full text
    Journal Article
  19. 19

    Vorapaxar and Amyotrophic Lateral Sclerosis: Coincidence or Adverse Association? by Serebruany, Victor L, Fortmann, Seth D, Hanley, Daniel F, Kim, Moo Hyun

    Published in American journal of therapeutics (01-03-2017)
    “…Vorapaxar, a novel antiplatelet thrombin PAR-1 inhibitor, is currently approved for post myocardial infarction and peripheral artery disease indications with…”
    Get full text
    Journal Article
  20. 20

    Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation by Serebruany, Victor L, Fortmann, Seth D, Rao, Sunil V, Tanguay, Jean-Francois, Lordkipanidze, Marie, Hanley, Daniel F, Can, Mehmet, Kim, Moo Hyun, Marciniak, Thomas A

    Published in Thrombosis and haemostasis (02-05-2016)
    “…Vorapaxar, a novel antiplatelet thrombin PAR-1 inhibitor, has been evaluated in the successful TRA2P trial and the failed TRACER trial. The drug is currently…”
    Get more information
    Journal Article